Key facts
- Notable investors include SBXi.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Auvra
- ·The full record, as it builds
Funding rounds
No funding rounds for Auvra are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Auvra
Developer of an AI-based wellness platform intended to focus on women's hormonal health. The company's platform provides personalized support for managing chronic hormonal imbalances, enabling patients to provide data-driven insights and actionable health tips.
- Sector
- Consumer Products and Services (B2C)
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 3
- Website
- hormoneinsight.ai/
- Ownership
- Privately Held (backing)
Auvra doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Auvra shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Auvra in its N-PORT filings yet. We sweep new filings monthly.